Results 71 to 80 of about 30,982 (215)

BNT162b2 Vaccine Encoding the SARS-CoV-2 P2 S Protects Transgenic hACE2 Mice against COVID-19

, 2021
BNT162b2 is a highly efficacious mRNA vaccine approved to prevent COVID-19. This brief report describes the immunogenicity and anti-viral protective effect of BNT162b2 in hACE2 transgenic mice.
Yumei Yang, Rui-Ru Ji, Chuan Qin, Hua Zhu, Ugur Sahin, Aimin Hui, Yajin Qu, Annette B. Vogel   +7 more
core   +1 more source

Humoral Immune Response of BNT162b2 and CoronaVac Vaccinations in Hemodialysis Patients: A Multicenter Prospective Cohort [PDF]

, 2022
The CoronaVac vaccine is the most used anti-SARS-CoV-2 vaccine worldwide. Previous data indicate that this vaccine produces a lower immune response than RNA vaccines such as BNT162b2.
Gajardo, Cynthia, Méndez Valdés, Gabriel Andrés, Angelica Ordenes, Toro, Luis, Josseline Aranda, Villa, Eduardo, Parra-Lucares, Alfredo, Zúñiga, José, Ordenes, Angelica, Toro Cabrera, Luis Alejandro, Luis Toro, Evelyn Mondaca, Jessica Tapia, Parra Lucares, Alfredo Andrés, Bravo, Karin, Karin Bravo, Tapia, Jessica, Andoni Etcheverry, José Zúñiga, Gabriel Méndez-Valdés, Brignardello, Rose, Evelyn Colombo, Alfredo Parra-Lucares, Aranda, Josseline, Rose Brignardello, Clavero, Rene, Bravo Espinoza, Karin Constanza, Mondaca, Evelyn, Eduardo Villa, Colombo, Evelyn, Etcheverry, Andoni, Cynthia Gajardo, Rene Clavero, Méndez-Valdés, Gabriel   +33 more
core   +1 more source

Physical Characteristics of Injection Site Pain After COVID-19 mRNA BNT162b2 Vaccination [PDF]

Background: BNT162b2, an mRNA COVID-19 vaccine, was launched in many countries as an intramuscular vaccination for COVID-19 infection. Few studies have assessed the physical indications of pain at the immunization site.
Hasegawa, Junnichi, Ikeuchi, Tomoyuki, 70325009, 50343281, 100000112, Sugihara, Shuji, 16816, Yamasaki, Akira, Okada, Shinichi, 100000447, ヤマサキ, アキラ, Tomita, Katsuki, 4358, 16815, 16814, Touge, Hirokazu, 16813, 16812, 2857   +18 more
core   +1 more source

Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination Strategy

Vaccines, 2022
In the present study, antibody and T cell-mediated immune responses elicited by BBIBP-CorV and BNT162b2 vaccines were compared 6 months after the two-dose immunization of healthy individuals.
Zsolt Matula, Márton Gönczi, Gabriella Bekő, Béla Kádár, Éva Ajzner, Ferenc Uher, István Vályi-Nagy   +6 more
doaj   +1 more source

Bridging the translational gap in clinical nanomedicine: From rational design to clinical reality

BMEMat, EarlyView.
Nanotechnology offers a multi‐faceted approach to modern healthcare, encompassing high‐sensitivity diagnostic imaging, innovative vaccine delivery, and targeted therapeutics. This review explores how these nanomedicine applications address critical challenges in cancer recurrence and the treatment of neurologic and respiratory diseases to combat rising
Ahmed H. Ghonaim, Marwa Ahmed El‐Naka, Wedad M. Nageeb, Atta Ullah Khan, Noura M. Seleem, Aliaa Abdelghafar, Doaa Zamel, Yang Liu, Qigai He, Wentao Li   +9 more
wiley   +1 more source

Protection by a Fourth Dose of BNT162b2 against Omicron in Israel

New England Journal of Medicine, 2022
On January 2, 2022, Israel began administering a fourth dose of BNT162b2 vaccine to persons 60 years of age or older. Data are needed regarding the effect of the fourth dose on rates of confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and of severe coronavirus disease 2019 (Covid-19).Using the Israeli Ministry of Health ...
Yinon M, Bar-On, Yair, Goldberg, Ron, Milo   +2 more
openaire   +5 more sources

Rare Adverse Events Associated with BNT162b2 mRNA Vaccine (Pfizer-BioNTech): A Review of Large-Scale, Controlled Surveillance Studies

Vaccines, 2022
Given the increasing anti-vaccine movements erroneously touting vaccine danger, this review has investigated the rare adverse events potentially associated with BNT162b2 (Pfizer-BioNTech), an mRNA vaccine against the severe acute respiratory distress ...
Shin-Jie Yong, Alice Halim, Michael Halim, Abbas Al Mutair, Saad Alhumaid, Jehad Al-Sihati, Hawra Albayat, Mohammed Alsaeed, Mohammed Garout, Reyouf Al Azmi, Noor Aldakheel, Abeer N. Alshukairi, Hani A. Al Ali, Adel A. Almoumen, Ali A. Rabaan   +14 more
doaj   +1 more source

Velociraptor Machine Learning Quantifies Similarity to Known Cell Types and Matches Cells Across Flow and Imaging Cytometry Platforms

Cytometry Part A, EarlyView.
ABSTRACT Suspension flow cytometry enables high‐throughput cellular profiling at the single cell level, but these data lack positional information. Conversely, tissue‐based imaging cytometry techniques reveal a cell's location within the tissue architecture and can provide insight into cell biology.
Claire E. Cross, Asa A. Brockman, Rebecca A. Ihrie, Jonathan M. Irish   +3 more
wiley   +1 more source

Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapy

BMC Rheumatology, 2023
Background The importance of COVID-19 vaccination for patients on immunosuppressive (IS) medication has increased due to the high risk of severe disease or mortality.
Fulya Cosan, Ozlem Unay Demirel, Demet Yalcin, Muhammed Mert Sonkaya, Isilsu Ezgi Uluisik, Olida Cecen, Yavuz Furuncuoglu, Deniz Maktav Celikmen, Osman Kara, Erkan Ceylan, Timucin Avsar   +10 more
doaj   +1 more source

Comparison of antibody response durability of mRNA-1273, BNT162b2, and Ad26.COV2.S SARS-CoV-2 vaccines in healthcare workers

International Journal of Infectious Diseases, 2022
Objectives: There are limited comparative immunologic durability data post COVID-19 vaccinations. Methods: Approximately 8.4 months after primary COVID-19 vaccination, 647 healthcare workers completed surveys about COVID-19 vaccinations/infections and ...
Wendy M. Brunner, Daniel Freilich, Jennifer Victory, Nicole Krupa, Melissa B. Scribani, Paul Jenkins, Emily G. Lasher, Amanda Fink, Anshini Shah, Peggy Cross, Valerie Bush, Laura J. Peek, Gary A. Pestano, Anne M. Gadomski   +13 more
doaj   +1 more source